4 Matching Annotations
  1. Aug 2022
  2. www.nature.com www.nature.com
    Brain changes after COVID revealed by imaging
    1
    1. chaeyeonlim 26 Aug 2022

      Gollub, R. L. (2022). Brain changes after COVID revealed by imaging. Nature. https://doi.org/10.1038/d41586-022-00503-x

      is:news lang:en COVID-19 brain changes research data infection neuroimaging longitudinal study neruopsychiatric symptom UK biobank MRI comparison omicron variant viral effect IDP
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/d41586-022-00503-x
  3. Oct 2021
  4. pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
    Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load
    1
    1. Marlene_Wulf 31 Oct 2021

      Kennedy-Shaffer, L., Kahn, R., & Lipsitch, M. (2021). Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load. Epidemiology (Cambridge, Mass.), 32(6), 820–828. https://doi.org/10.1097/EDE.0000000000001415

      is:article lang:en COVID-19 vaccine efficacy transmission viral load effect estimation effectiveness symptomatic infection asymptomatic infection
    Visit annotations in context

    Tags

    Annotators

    URL

    pubmed.ncbi.nlm.nih.gov/34469363/
  5. www.hindustantimes.com www.hindustantimes.com
    ICMR removes Ivermectin, HCQ from revised guidelines on Covid-19 treatment
    1
    1. jasminehollingworth 04 Oct 2021

      ICMR removes Ivermectin, HCQ from revised guidelines on Covid-19 treatment. (2021, September 24). Hindustan Times. https://www.hindustantimes.com/india-news/icmr-removes-ivermectin-hcq-from-revised-guidelines-on-covid-19-treatment-101632461755113.html

      lang:en is:news COVID-19 India guideline treatment drug medicine evidence effect viral load symptom dose data trial benefit
    Visit annotations in context

    Tags

    Annotators

    URL

    hindustantimes.com/india-news/icmr-removes-ivermectin-hcq-from-revised-guidelines-on-covid-19-treatment-101632461755113.html
  6. Sep 2021
  7. www.nejm.org www.nejm.org
    Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
    1
    1. XanaButt 03 Sep 2021

      Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernán, M. A., Lipsitch, M., Kohane, I., Netzer, D., Reis, B. Y., & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMoa2110475

      is:article lang:en COVID-19 vaccine safety mRNA side effect adverse research Israel comparison myocarditis infection viral infection
    Visit annotations in context

    Tags

    Annotators

    URL

    nejm.org/doi/full/10.1056/NEJMoa2110475